Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miho Nagayasu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmaceutical Research|March 30, 2021
Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic miceMiho Nagayasu, Kazuhisa Ozeki
Pharmaceutical Research|June 2, 2023
Development of a New Method to Evaluate the Biodistribution of Antibodies Using Non-Radioactive Metal Labeling and Inductively Coupled Plasma Mass SpectrometryMiho Nagayasu, Yoko Takano, Kazuhisa Ozeki
Biological & Pharmaceutical Bulletin|September 3, 2019
Three-Compartment Model Analysis with Minimal Sampling Points in the Caco-2 Permeability AssayMiho Nagayasu, Kazuhisa Ozeki, Satomi Onoue
Pharmaceutical Research|December 25, 2019
Simplified Method to Determine the Efflux Ratio on P-Glycoprotein Substrates Using Three-Compartment Model Analysis for Caco-2 Cell Assay DataMiho Nagayasu, Kazuhisa Ozeki, Yuuji Sakurai, et al.
Biological & Pharmaceutical Bulletin|May 8, 2020
Predicting Method for the Human Plasma Concentration-Time Profile of a Monoclonal Antibody from the Half-life of Non-human PrimatesGenki Nakamura, Kazuhisa Ozeki, Miho Nagayasu, et al.
Drug Metabolism and Pharmacokinetics|October 16, 2013
Assessing the impact of HER2 status on the antitumor activity of an HSP90 inhibitor in human tumor xenograft mice using pharmacokinetic-pharmacodynamic modelingRyoichi Saitoh, Miho Nagayasu, Norihito Shibahara, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 17, 2021
<i>In vivo</i>-<i>in vitro</i> correlation of antitumor activity of heat shock protein 90 (HSP90) inhibitors with a pharmacokinetics/pharmacodynamics analysis using NCI-N87 xenograft miceNoriaki Ohminato, Miho Nagayasu, Kazuhisa Ozeki, et al.
The Journal of Toxicological Sciences|January 15, 2014
Retinal toxicity induced by small-molecule Hsp90 inhibitors in beagle dogsChisako Kanamaru, Yuichiro Yamada, Shuji Hayashi, et al.
Pharmaceutical Research|March 24, 2026
Development of a Dual-Isotope Imaging Technique for Simultaneous Quantification and Evaluation of Biodistribution of Antibodies Using "XCam-CdTe"Miho Nagayasu, Miho Katsuragawa, Kazuhisa Ozeki, et al.
European Journal of Pharmacology|April 3, 2010
Possible protective role of pregnenolone-16 alpha-carbonitrile in lithocholic acid-induced hepatotoxicity through enhanced hepatic lipogenesisMasaaki Miyata, Masahiro Nomoto, Fumiaki Sotodate, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|March 30, 2021
Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic miceMiho Nagayasu, Kazuhisa Ozeki
Pharmaceutical Research|June 2, 2023
Development of a New Method to Evaluate the Biodistribution of Antibodies Using Non-Radioactive Metal Labeling and Inductively Coupled Plasma Mass SpectrometryMiho Nagayasu, Yoko Takano, Kazuhisa Ozeki
Biological & Pharmaceutical Bulletin|September 3, 2019
Three-Compartment Model Analysis with Minimal Sampling Points in the Caco-2 Permeability AssayMiho Nagayasu, Kazuhisa Ozeki, Satomi Onoue
Pharmaceutical Research|December 25, 2019
Simplified Method to Determine the Efflux Ratio on P-Glycoprotein Substrates Using Three-Compartment Model Analysis for Caco-2 Cell Assay DataMiho Nagayasu, Kazuhisa Ozeki, Yuuji Sakurai, et al.
Biological & Pharmaceutical Bulletin|May 8, 2020
Predicting Method for the Human Plasma Concentration-Time Profile of a Monoclonal Antibody from the Half-life of Non-human PrimatesGenki Nakamura, Kazuhisa Ozeki, Miho Nagayasu, et al.
Drug Metabolism and Pharmacokinetics|October 16, 2013
Assessing the impact of HER2 status on the antitumor activity of an HSP90 inhibitor in human tumor xenograft mice using pharmacokinetic-pharmacodynamic modelingRyoichi Saitoh, Miho Nagayasu, Norihito Shibahara, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 17, 2021
<i>In vivo</i>-<i>in vitro</i> correlation of antitumor activity of heat shock protein 90 (HSP90) inhibitors with a pharmacokinetics/pharmacodynamics analysis using NCI-N87 xenograft miceNoriaki Ohminato, Miho Nagayasu, Kazuhisa Ozeki, et al.
The Journal of Toxicological Sciences|January 15, 2014
Retinal toxicity induced by small-molecule Hsp90 inhibitors in beagle dogsChisako Kanamaru, Yuichiro Yamada, Shuji Hayashi, et al.
Pharmaceutical Research|March 24, 2026
Development of a Dual-Isotope Imaging Technique for Simultaneous Quantification and Evaluation of Biodistribution of Antibodies Using "XCam-CdTe"Miho Nagayasu, Miho Katsuragawa, Kazuhisa Ozeki, et al.
European Journal of Pharmacology|April 3, 2010
Possible protective role of pregnenolone-16 alpha-carbonitrile in lithocholic acid-induced hepatotoxicity through enhanced hepatic lipogenesisMasaaki Miyata, Masahiro Nomoto, Fumiaki Sotodate, et al.
Pageof 2